SOP Guide for Pharma

Tablets: SOP for Handling Non-Conforming Products During Manufacturing – V 2.0

Tablets: SOP for Handling Non-Conforming Products During Manufacturing – V 2.0

Standard Operating Procedure for Handling Non-Conforming Products During Manufacturing

Department Tablet
SOP No. SOP/TAB/218/2025
Supersedes SOP/TAB/218/2022
Page No. Page 1 of 5
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

This SOP defines the procedures for identifying, handling, and resolving non-conforming products during the tablet manufacturing process. Its goal is to ensure that non-conforming products are properly managed to prevent their distribution and to improve overall product quality.

2. Scope

This SOP applies to all non-conforming products detected during tablet manufacturing, including raw materials, intermediates, and finished tablets. It covers all activities from identification, segregation, investigation, corrective actions, and documentation.

3. Responsibilities

  • Production Manager: Responsible for identifying non-conforming products, ensuring their proper segregation, and reporting them to the Quality Assurance (QA) team.
  • Quality Control (QC) Team: Responsible for evaluating the non-conforming products, conducting investigations, and providing recommendations for corrective actions.
  • Quality Assurance (QA) Manager: Responsible for overseeing the resolution of non-conformances, reviewing investigation reports, and ensuring compliance with regulatory requirements.
  • Regulatory Affairs Team: Ensures that non-conforming products are handled according to regulatory guidelines, especially when deviations could affect product compliance or safety.

4. Accountability

The QA Manager is accountable

for ensuring that the non-conforming products are properly handled, investigated, and resolved according to this SOP. The Production Manager and QC Team are responsible for identifying, segregating, and reporting non-conformances.

5. Procedure

5.1 Identification and Segregation of Non-Conforming Products

  1. Identify non-conforming products through in-process inspections, QC testing, or visual examination during manufacturing (e.g., tablets failing hardness or disintegration testing).
  2. Immediately segregate non-conforming products from conforming products to prevent cross-contamination or accidental release.
  3. Label the non-conforming products clearly with a “Non-Conforming Product” label and place them in a designated quarantine area.
  4. Document the details of the non-conformance, including the batch number, product name, and nature of the non-conformance (Annexure-1).

5.2 Investigation of Non-Conformance

  1. The QC Team investigates the root cause of the non-conformance by reviewing batch records, conducting product testing, and analyzing the manufacturing process (Annexure-2).
  2. Use appropriate investigative techniques such as Root Cause Analysis (RCA) to identify the underlying cause of the non-conformance (Annexure-3).
  3. Document all findings from the investigation, including potential causes, impacts, and corrective action recommendations (Annexure-4).

5.3 Corrective Actions

  1. Develop corrective actions based on the investigation findings to address the root cause and prevent recurrence of the non-conformance (Annexure-5).
  2. Implement corrective actions as soon as possible and document all actions taken (Annexure-6).
  3. Verify the effectiveness of corrective actions by conducting follow-up inspections and testing of products produced after implementation (Annexure-7).

5.4 Reprocessing or Disposition of Non-Conforming Products

  1. If a non-conforming product can be reprocessed or reworked to meet quality specifications, provide detailed instructions on the steps to follow (e.g., re-blending, re-compressing, or re-coating) (Annexure-8).
  2. If the non-conforming product cannot be reprocessed or reworked, it must be properly disposed of according to the company’s waste disposal procedures (Annexure-9).
  3. Ensure that all reprocessed or disposed products are documented appropriately, with proper tracking and accountability (Annexure-10).

5.5 Documentation and Record Keeping

  1. Ensure that all records related to non-conforming products, investigations, corrective actions, and reprocessing or disposal are documented and securely stored (Annexure-11).
  2. Retain all records for a minimum of 5 years or as required by applicable regulations.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • CAPA: Corrective and Preventive Action

7. Documents

  1. Non-Conformance Report (Annexure-1)
  2. Investigation Report (Annexure-2)
  3. Root Cause Analysis Report (Annexure-3)
  4. Corrective Action Plan (Annexure-4)
  5. Corrective Action Implementation Record (Annexure-5)
  6. Reprocessing Instructions (Annexure-6)
  7. Disposal Records (Annexure-7)
  8. Reprocessing and Disposal Documentation (Annexure-8)
  9. Non-Conformance Documentation (Annexure-9)

8. References

  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • ISO 9001 – Quality Management Systems
  • GMP Guidelines for Pharmaceutical Manufacturing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Non-Conformance Report

Non-Conformance ID Description Batch Number Action Taken
NC001 Potency Out of Specification Batch123 Recalibrated equipment and retested

Annexure-2: Investigation Report

Investigation ID Findings Corrective Action
INV001 Improper calibration of equipment Recalibrate equipment and perform routine checks

Annexure-3: Root Cause Analysis Report

Cause ID Root Cause Description Corrective Action
RCA001 Inconsistent calibration of tablet hardness tester Establish routine calibration schedule

Annexure-4: Corrective Action Plan

Action ID Action Description Completion Date
CAP001 Recalibrate equipment 06/03/2026

Annexure-5: Corrective Action Implementation Record

Action ID Action Implemented By Result
CAP001 Jane Smith Successfully recalibrated equipment

Annexure-6: Reprocessing Instructions

Batch Number Reprocessing Instructions Completion Date
Batch123 Re-blend and compress 06/03/2026

Annexure-7: Disposal Records

Batch Number Disposal Method Disposal Date
Batch123 Incineration 06/03/2026

Annexure-8: Reprocessing and Disposal Documentation

Batch Number Action Taken Completion Date
Batch123 Reprocessing completed 06/03/2026

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP creation New process QA Head
01/02/2025 2.0 Added documentation and tracking requirements Annual review QA Head
Exit mobile version